التفاصيل البيبلوغرافية
| العنوان: |
Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma. |
| المؤلفون: |
Cheng, Suk H., Haiqiang Zhang, Wenlei Peng, Tse, O. Y. Olivia, Tong, Yu K., Wanxia Gai, Peiyong Jiang, Chan, K. C. Allen, Chiu, Rossa W. K., Lo, Y. M. Dennis, Lam, W. K. Jacky, Ma, Brigette B. Y., Hui, Edwin P., Chan, Anthony T. C., Woo, John K. S., Zee, Benny C. Y. |
| المصدر: |
Proceedings of the National Academy of Sciences of the United States of America; 5/29/2018, Vol. 115 Issue 22, pE5115-E5124, 10p, 2 Charts, 4 Graphs |
| مصطلحات موضوعية: |
NASOPHARYNX, CARCINOMA, PREDICTIVE validity, DNA analysis, DNA, CHARTS, diagrams, etc. |
| مستخلص: |
Circulating tumor-derived DNA testing for cancer screening has recently been demonstrated in a prospective study on identification of nasopharyngeal carcinoma (NPC) among 20,174 asymptomatic individuals. Plasma EBV DNA, a marker for NPC, was detected using real-time PCR. While plasma EBV DNA was persistently detectable in 97.1% of the NPCs identified, ∼5% of the general population had transiently detectable plasma EBV DNA. We hypothesized that EBV DNA in plasma of subjects with or without NPC may have different molecular characteristics. We performed target-capture sequencing of plasma EBV DNA and identified differences in the abundance and size profiles of EBV DNA molecules within plasma of NPC and non-NPC subjects. NPC patients had significantly higher amounts of plasma EBV DNA, which showed longer fragment lengths. Cutoff values were established from an exploratory dataset and tested in a validation sample set. Adopting an algorithm that required a sample to concurrently pass cutoffs for EBV DNA counting and size measurements, NPCs were detected at a positive predictive value (PPV) of 19.6%. This represented superior performance compared with the PPV of 11.0% in the prospective screening study, which required participants with an initially detectable plasma EBV DNA result to be retested within 4 weeks. The observed differences in the molecular nature of EBV DNA molecules in plasma of subjects with or without NPC were successfully translated into a sequencing-based test that had a high PPV for NPC screening and achievable through single timepoint testing. [ABSTRACT FROM AUTHOR] |
|
Copyright of Proceedings of the National Academy of Sciences of the United States of America is the property of National Academy of Sciences and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
